Bionano Genomics Inc expected to post a loss of $2.41 a share - Earnings Preview

Bionano Genomics

01/08/2025 22:00

Bionano Genomics Inc BNGO.OQ BNGO.O is expected to  show a fall in quarterly revenue when it reports  results on August 5 for the period ending June 30 2025

The San Diego California-based  company is expected to report a 9.9% decrease in revenue to $6.999 million from $7.77 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on May 14 2025, for the period ended June 30, was for revenue between $6.30 million and $6.80 million.

​LSEG's mean analyst estimate for Bionano Genomics Inc is for a loss of $2.41 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Bionano Genomics Inc is $8.00, about 62.4% above its last closing price of $3.01

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-3.32
-3.02
-1.15
Beat
61.9
Dec. 31 2025
-6.00
-15.83
Missed
-163.8
Sep. 30 2024
-11.92
-12.60
-24.00
Missed
-90.5​
Jun. 30 2024
-24.74
-25.00
-13.20
Beat
47.2
​​Mar. 31 2024
-38.68
-38.70
-30.60
Beat
20.9
Dec. 31 2023
-52.16
-52.35
-24.60
Beat
53​
Sep. 30 2023
-55.33
-58.20
-60.00
Missed
-3.1
Jun. 30 2023
-60.00
-62.00
-74.40
Missed
-20

This summary was machine generated August 1 at 21:00 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)